Genmab AS(GMAB)— 技术面状态
数据截至2026-09-21 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades +10% vs the 50-day and +17.7% vs the 200-day average, 2.1% below the 52-week high and +46.9% off the 52-week low; a golden cross printed 18 sessions ago. Computed from daily closes.
均线状态
- 相对20日均线+3%
- 相对50日均线+10%
- 相对200日均线+17.7%
- 52周区间低于52周高点2.1% · 高于52周低点46.9%
- 连续走势连续1个交易日下跌
- 均线交叉金叉(18个交易日前)
- 50日均线交叉股价向上穿越50日均线(57个交易日前)
- 随机指标%K 84.4 · %D 88.8(死叉)
FAQ · from the current data · as of 2026-09-21
Quick answers
GMAB当前的Closelook信号是什么?
Uptrend stack intact — Trades +10% vs the 50-day and +17.7% vs the 200-day average, 2.1% below the 52-week high and +46.9% off the 52-week low; a golden cross printed 18 sessions ago. Computed from daily closes.(截至2026-09-21;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
GMAB目前是否位于50日和200日均线上方?
截至2026-09-21,Genmab AS位于50日均线上方(+10%),200日均线上方(+17.7%);距20日均线+3%。
GMAB距52周高点有多远?
截至2026-09-21,低于52周高点2.1%,高于52周低点46.9%。
Related in the Closelook universe
then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- RXRX Recursion Pharmaceuticals Incindustry
- HALO Halozyme Therapeutics Incindustry
- SMMT Summit Therapeutics PLCindustry
- CRSP Crispr Therapeutics AGindustry
- IBRX Immunitybio Incindustry
- SRPT Sarepta Therapeutics Incindustry
- TGTX TG Therapeutics Incindustry
- EXEL Exelixis Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- INCY Incyte Corporationindustry
- PCVX Vaxcyte Incindustry